Breaks Categories: Stock Spotlights

ThursdayOct 19, 2017 12:24 pm

CBDNewsBreaks – Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators

Constant growth within the legal marijuana and hemp industries also means increasingly fierce competition in this burgeoning market, which makes it more and more difficult for companies in the cannabis space to stand out from the pack. Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model. An article discussing this reads: “The exponential growth of the legal cannabis market and the hemp-based CBD industry enables Marijuana Company of America to fully develop its vertically integrated business…

Continue Reading

FridayOct 13, 2017 11:16 am

CBDNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

Continue Reading

ThursdayOct 12, 2017 2:27 pm

CBDNewsBreaks – Why Skinvisible, Inc. (SKVI) is Worth Watching in a $65B Market

Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is an R&D company offering its patented Invisicare® technology, which can be used to revitalize or create new medical or skincare products, thus enabling companies that license Skinvisible’s formulations to sell their own patented products and ward off generic rivals. A high-performance topical and transdermal delivery system, Invisicare enhances the delivery of drugs and other ingredients to and through the skin utilizing Skinvisible’s innovative formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions.  An article discussing this reads: “A prescription dermatology product…

Continue Reading

ThursdayOct 12, 2017 9:30 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids

Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology. This technology is already being applied to the use of non-psychoactive cannabinoids, yielding a high-absorption hemp oil formula that is a source of omega and fatty acids, and patents are pending for tetrahydrocannabinol (THC) and other psychoactive cannabinoids along with nicotine and nonsteroidal anti-inflammatory drugs. An article discussing this reads: “The patent awarded to LXRP for the delivery of all non-psychoactive…

Continue Reading

ThursdayOct 12, 2017 9:30 am

CBDNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)

EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs has performed more than 50,000 tests and has evolved from operating one laboratory in Oregon to having nine labs that span California, Oregon, Colorado, Massachusetts and Florida. An article discussing this reads: “EVIO Labs is driving the cannabis testing industry by providing clients nationwide with…

Continue Reading

WednesdayOct 11, 2017 2:35 pm

CBDNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Sharpens Focus on Potentially Game-Changing Sustained Release Cannabinoid Formulation

Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release cannabinoid formulation. The agreement grants Emblem the exclusive right to Canntab’s patents and expertise in Canada to develop, commercialize, use, sell and offer—but not import or export—the product, which will be sold under the Emblem brand. An article discussing this reads: “For pharmaceutical ingredients that are typically short-acting, like cannabinoids, sustained release formulations enable dosage schedules that are…

Continue Reading

WednesdayOct 11, 2017 2:34 pm

CBDNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scales Up in Preparation for Canada’s Impending 2018 Recreational Cannabis Legalization

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date. The company’s high-tech indoor growing environment—with every facet of the growing, curing and harvesting process controlled and monitored by computer—yields a high-quality product that is clean, steady and repeatable—something the company can effectively leverage should recreational cannabis legalization go through in 2018. An article discussing this reads: “Focused on scaling its operations and distinguishing itself through its proprietary organic and pesticide-free growing technology,…

Continue Reading

FridayOct 06, 2017 12:17 pm

CBDNewsBreaks – Algae Dynamics Corp. (ADYNF) Prepares for Increased Cannabis Demand in Canada

Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018. The company’s focus on the development of proprietary research and products utilizing cannabis-derived botanical oils addresses two areas of key interest to consumers: the noted health benefits of cannabinoids and smoke-free alternatives for marijuana consumption. An article discussing this reads: “Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once…

Continue Reading

TuesdayOct 03, 2017 1:23 pm

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of…

Continue Reading

TuesdayOct 03, 2017 1:21 pm

CBDNewsBreaks – India Globalization Capital (NYSE: IGC) Demonstrates Potential in Alzheimer’s Treatment Market

In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers. A recent IGC press release (http://cnw.fm/Cq71C) gave an update on in vitro data that has been compiled from genetically engineered cell lines in an Alzheimer’s disease model, demonstrating that, at varying THC concentrations, the aggregation of Aβ protein (the buildup of which has been linked to causing Alzheimer’s) decreases by up to 40 percent. An article further discussing this reads: “IGC…

Continue Reading